GENE ONLINE|News &
Opinion
Blog

Prostate Cancer
Breakthrough in Cancer Vaccine Development Enhances Effectiveness and Reach
2025-03-03
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
Deep Into Bankruptcy Proceedings, Clovis Sells Cancer Med Rubraca
2023-04-10
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Novartis’ Pluvicto Continues Winning Streak In Prostate Cancer Indication
2022-12-07
Janssen Drops Out of Prostate Cancer Clinical Trial Due to Lack of Patients
2022-11-01
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Day 3 ESMO 2021 Roundup: Mirati’s KRAS Drug Surpasses Amgen’s in Colorectal Cancer Trial
2021-09-20
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
1 2
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top